Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Takeuchi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Asian Journal of Pharmaceutical Sciences|February 28, 2020
Prediction of effects of punch shapes on tableting failure by using a multi-functional single-punch tablet pressTakashi Osamura, Yoshiko Takeuchi, Risako Onodera, et al.
Multidisciplinary Respiratory Medicine|April 18, 2014
Ambulatory pulse oximetry monitoring in Japanese COPD outpatients not receiving oxygen therapySeigo Minami, Suguru Yamamoto, Yoshitaka Ogata, et al.
International Journal of Pharmaceutics|May 28, 2018
Characterization of mannitol granules and powder: A comparative study using two flowability testersYoshiko Takeuchi, Tomoka Tomita, Junko Kuroda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 19, 2013
Emergency department visits after hours by lung cancer patients in JapanSeigo Minami, Suguru Yamamoto, Yoshitaka Ogata, et al.
Anticancer Research|December 11, 2013
Phase II trial of pemetrexed continuation--maintenance after carboplatin-based induction in untreated non-squamous non-small cell lung cancerSeigo Minami, Takashi Kijima, Kiyoshi Komuta, et al.
Blood|July 20, 2021
Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytesElena Tonc, Yoshiko Takeuchi, Chun Chou, et al.
BMC Cancer|July 20, 2012
Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding studySeigo Minami, Takashi Kijima, Ryo Takahashi, et al.
Cancer Immunology Research|May 20, 2024
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass SpectrometryWei Meng, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2013
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation statusSeigo Minami, Takashi Kijima, Masanari Hamaguchi, et al.
Science Immunology|February 2, 2020
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i>-mutated non-small cell lung cancerEri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Asian Journal of Pharmaceutical Sciences|February 28, 2020
Prediction of effects of punch shapes on tableting failure by using a multi-functional single-punch tablet pressTakashi Osamura, Yoshiko Takeuchi, Risako Onodera, et al.
Multidisciplinary Respiratory Medicine|April 18, 2014
Ambulatory pulse oximetry monitoring in Japanese COPD outpatients not receiving oxygen therapySeigo Minami, Suguru Yamamoto, Yoshitaka Ogata, et al.
International Journal of Pharmaceutics|May 28, 2018
Characterization of mannitol granules and powder: A comparative study using two flowability testersYoshiko Takeuchi, Tomoka Tomita, Junko Kuroda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 19, 2013
Emergency department visits after hours by lung cancer patients in JapanSeigo Minami, Suguru Yamamoto, Yoshitaka Ogata, et al.
Anticancer Research|December 11, 2013
Phase II trial of pemetrexed continuation--maintenance after carboplatin-based induction in untreated non-squamous non-small cell lung cancerSeigo Minami, Takashi Kijima, Kiyoshi Komuta, et al.
Blood|July 20, 2021
Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytesElena Tonc, Yoshiko Takeuchi, Chun Chou, et al.
BMC Cancer|July 20, 2012
Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding studySeigo Minami, Takashi Kijima, Ryo Takahashi, et al.
Cancer Immunology Research|May 20, 2024
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass SpectrometryWei Meng, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2013
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation statusSeigo Minami, Takashi Kijima, Masanari Hamaguchi, et al.
Science Immunology|February 2, 2020
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i>-mutated non-small cell lung cancerEri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, et al.
Pageof 3